IT8947938A0 - Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono - Google Patents

Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono

Info

Publication number
IT8947938A0
IT8947938A0 IT8947938A IT4793889A IT8947938A0 IT 8947938 A0 IT8947938 A0 IT 8947938A0 IT 8947938 A IT8947938 A IT 8947938A IT 4793889 A IT4793889 A IT 4793889A IT 8947938 A0 IT8947938 A0 IT 8947938A0
Authority
IT
Italy
Prior art keywords
preparing
procedure
contain
pharmaceutical compositions
adsorbates
Prior art date
Application number
IT8947938A
Other languages
English (en)
Other versions
IT1232831B (it
Inventor
Stephen John Douglas
Fiona Ruth Bird
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888811167A external-priority patent/GB8811167D0/en
Priority claimed from GB888816185A external-priority patent/GB8816185D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8947938A0 publication Critical patent/IT8947938A0/it
Application granted granted Critical
Publication of IT1232831B publication Critical patent/IT1232831B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
IT8947938A 1988-05-11 1989-05-10 Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono IT1232831B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888811167A GB8811167D0 (en) 1988-05-11 1988-05-11 Medicaments
GB888816185A GB8816185D0 (en) 1988-07-07 1988-07-07 Medicaments

Publications (2)

Publication Number Publication Date
IT8947938A0 true IT8947938A0 (it) 1989-05-10
IT1232831B IT1232831B (it) 1992-03-05

Family

ID=26293879

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8947938A IT1232831B (it) 1988-05-11 1989-05-10 Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono

Country Status (35)

Country Link
US (1) US5032393A (it)
JP (1) JP2944678B2 (it)
KR (1) KR890016968A (it)
CN (1) CN1027133C (it)
AT (1) AT401614B (it)
AU (1) AU624613B2 (it)
BE (1) BE1002159A5 (it)
CA (1) CA1337272C (it)
CH (1) CH679011A5 (it)
CY (1) CY1781A (it)
DE (1) DE3915347C2 (it)
DK (1) DK168934B1 (it)
ES (1) ES2011573A6 (it)
FI (1) FI92060C (it)
FR (1) FR2631232B1 (it)
GB (1) GB2218333B (it)
GR (1) GR1000358B (it)
HK (1) HK45094A (it)
HU (2) HU204994B (it)
IE (1) IE60722B1 (it)
IL (1) IL90245A (it)
IT (1) IT1232831B (it)
LU (1) LU87515A1 (it)
MX (1) MX173349B (it)
MY (1) MY104013A (it)
NL (1) NL8901188A (it)
NO (1) NO175131C (it)
NZ (1) NZ229064A (it)
PH (1) PH27612A (it)
PL (1) PL279377A1 (it)
PT (1) PT90523B (it)
RU (1) RU2033155C1 (it)
SE (1) SE508343C2 (it)
SG (1) SG48194G (it)
YU (1) YU47674B (it)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
CA2098200A1 (en) * 1990-12-21 1992-06-21 William Joseph Kelleher Polyamine drug-resin complexes
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
GB9211148D0 (en) * 1992-05-26 1992-07-08 Smithkline Beecham Plc Novel treatment
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
CA2121435C (en) * 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
GB9324409D0 (en) * 1993-11-27 1994-01-12 Smithkline Beecham Plc Novel composition
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
CN1278738A (zh) * 1997-11-10 2001-01-03 久光制药株式会社 药剂用缓释和含有该缓释剂的缓释性药物组合物
JP4283355B2 (ja) * 1997-11-10 2009-06-24 久光製薬株式会社 薬剤用徐放化剤及びそれを含有した徐放性医薬組成物
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
ATE411047T1 (de) * 1999-07-14 2008-10-15 Schering Plough Ltd Maskieren des geschmacks der oralen flüssigen chinolon-zubereitungen mit ionenaustauscherharzen
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
JP4268052B2 (ja) * 2002-01-18 2009-05-27 ローム アンド ハース カンパニー レジネートの調製方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20050142097A1 (en) * 2003-12-29 2005-06-30 Deepak Thassu Multiple active drug resin conjugate
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
EP1898913A1 (en) * 2005-06-28 2008-03-19 Ucb, S.A. Multiple active drug-resin conjugate
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
BRPI0709606B8 (pt) 2006-03-16 2021-05-25 Tris Pharma Inc suspensão líquida administrável oralmente com características de liberação modificada
CN100411626C (zh) * 2006-08-28 2008-08-20 浙江大学 缓释型碘补充剂的制备方法
US8287848B2 (en) 2006-10-03 2012-10-16 Tris Pharma Inc Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
CN100450548C (zh) * 2006-12-22 2009-01-14 江苏奥赛康药业有限公司 一种波拉克林树脂组合物的口腔贴片及其制备方法
MY185299A (en) * 2007-10-11 2021-04-30 Philip Morris Products Sa Smokeless tobacco product
WO2009102830A1 (en) * 2008-02-13 2009-08-20 Eurand Inc Orally disintegrating tablet compositions of ranitidine and methods of manufacture
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
US8357398B2 (en) * 2009-10-21 2013-01-22 Alitair Pharmaceuticals Inc. Benzonatate compositions and methods of use
CN102198118B (zh) * 2011-03-28 2012-08-29 于晓勇 一种治疗呕吐的口腔药物制剂及其制备方法
CN102138915A (zh) * 2011-03-28 2011-08-03 于晓勇 一种口服药物制剂及其制备方法
EP2884961B1 (en) 2012-08-15 2019-03-06 Tris Pharma Inc. Methylphenidate extended release chewable tablet
US20200038376A1 (en) * 2016-11-01 2020-02-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
EP3784214A4 (en) 2018-04-27 2022-01-19 Johnson & Johnson Consumer Inc. LIQUID ORAL PHARMACEUTICAL DOSAGE FORM

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR803638A (fr) * 1935-06-21 1936-10-05 Système de freinage pour portes coulissantes
US2828207A (en) * 1955-11-14 1958-03-25 Du Pont Fortification of feed
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US2970053A (en) * 1958-10-28 1961-01-31 Pfizer & Co C Oleandomycin resin adsorbate
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
US3949068A (en) * 1964-02-20 1976-04-06 University Of Alabama In Birmingham Medical And Educational Foundation Pharmaceutical compositions
GB1180233A (en) * 1966-02-23 1970-02-04 Jean Astruc Modified Spiramycin
US3624209A (en) * 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
JPS5146154B2 (it) * 1972-05-11 1976-12-07
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
JPS51125708A (en) * 1974-07-23 1976-11-02 Beecham Group Ltd Production of betaalactam antibiotic complex
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
JPS6369038A (ja) * 1986-09-10 1988-03-29 Canon Inc 光カ−ド記録媒体
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents

Also Published As

Publication number Publication date
ES2011573A6 (es) 1990-01-16
BE1002159A5 (fr) 1990-08-14
HU204994B (en) 1992-03-30
IL90245A0 (en) 1989-12-15
FI92060C (fi) 1994-09-26
RU2033155C1 (ru) 1995-04-20
YU97189A (en) 1990-06-30
NO175131B (no) 1994-05-30
FI92060B (fi) 1994-06-15
GB2218333B (en) 1991-11-06
AU3461789A (en) 1989-11-16
DK229489A (da) 1989-11-12
SE8901671L (sv) 1989-11-12
AU624613B2 (en) 1992-06-18
YU47674B (sh) 1996-01-08
NO175131C (no) 1994-09-07
US5032393A (en) 1991-07-16
MY104013A (en) 1993-10-30
IE60722B1 (en) 1994-08-10
FI892248A (fi) 1989-11-12
PT90523A (pt) 1989-11-30
CY1781A (en) 1995-10-20
GB2218333A (en) 1989-11-15
NZ229064A (en) 1991-12-23
JPH02111719A (ja) 1990-04-24
MX15983A (es) 1993-10-01
NL8901188A (nl) 1989-12-01
PL279377A1 (en) 1990-01-22
PH27612A (en) 1993-08-31
PT90523B (pt) 1994-10-31
IL90245A (en) 1994-04-12
HUT50036A (en) 1989-12-28
CN1027133C (zh) 1994-12-28
HK45094A (en) 1994-05-13
CN1037651A (zh) 1989-12-06
FR2631232A1 (fr) 1989-11-17
LU87515A1 (fr) 1990-06-12
GB8910706D0 (en) 1989-06-28
SG48194G (en) 1994-11-25
GR890100314A (en) 1990-03-12
AT401614B (de) 1996-10-25
HU211592A9 (en) 1995-12-28
CH679011A5 (it) 1991-12-13
FR2631232B1 (fr) 1993-11-19
JP2944678B2 (ja) 1999-09-06
KR890016968A (ko) 1989-12-14
DK229489D0 (da) 1989-05-10
NO891906D0 (no) 1989-05-10
CA1337272C (en) 1995-10-10
DE3915347A1 (de) 1989-11-16
NO891906L (no) 1989-11-13
MX173349B (es) 1994-01-22
ATA112089A (de) 1996-03-15
DE3915347C2 (de) 1994-11-03
SE8901671D0 (sv) 1989-05-10
GR1000358B (el) 1992-06-30
IT1232831B (it) 1992-03-05
FI892248A0 (fi) 1989-05-10
IE891527L (en) 1989-11-11
DK168934B1 (da) 1994-07-11
SE508343C2 (sv) 1998-09-28

Similar Documents

Publication Publication Date Title
IT8947938A0 (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
IT8747630A0 (it) Derivati di dicloroanilina, composizioni farmaceutiche che li contengono e procedimento per produrli
IL91126A0 (en) Substituted aminomethyl-tetralins and their heterocyclic analogues,their preparation and pharmaceutical compositions containing them
IL92518A0 (en) Aminobenzoates,their preparation and pharmaceutical compositions containing them
KR880005932A (ko) 신경중독손상을 감소시키기 위한 약제 조성물
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
IT8748642A0 (it) Chetoni triciclici,procedimento per prepararli e composizioni farmaceutiche che li contengono
IL92533A0 (en) Imidazoles,their preparation and pharmaceutical compositions containing them
FI893643A (fi) Farmaceutiska kompositioner.
IT8548869A0 (it) Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
IT8348155A0 (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT8548921A0 (it) Derivati di indolo,procedimento,per prepararli e composizioni farmaceutiche che li contengono
IT8548348A0 (it) Derivati di amminofenolo,procedimento per prepararli e composizione farmaceutica che li contiene
IT1240350B (it) Derivati di tieno-triazolo-diazepine,un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT1240935B (it) Derivati di tieno-triazolo-diazepine, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
NZ218837A (en) Melphalan derivatives and pharmaceutical compositions
IT8648547A0 (it) Derivati di dicloroanilina,procedimento per prepararli e composizioni farmaceutiche che li contengono
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
NZ223682A (en) Pyridazine-substituted benzimidazoles, and pharmaceutical compositions containing them
IL69777A (en) N-(1-(4-amino-6,7-dialkoxy-2-quinazolinyl)-4-piperidyl)-oxozolidine-2,4-diones,their preparation and pharmaceutical compositions containing them
IL89377A0 (en) Substituted imidazolinones and imidazolinethiones,their preparation and pharmaceutical compositions containing them
IL89664A0 (en) Disubstituted pyrroles,their preparation and pharmaceutical compositions containing them
IL90044A0 (en) Imidazolylmethyl-cycloalkane(b)indolones,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530